Navigation Links
Independent publication supports the profile of CeNeS phase II,compound, CNS 5161

oncept clinical trials as a novel compound for the treatment of neuropathic pain. Two Phase I studies using CNS 5161 administered intravenously have been completed in male volunteers. The first study demonstrated the safety and tolerability of selected doses of CNS 5161 and the second that at a dose of CNS 5161 that was well tolerated, analgesic effects were evident in an experimental model of pain. Two phase IIa studies have been completed giving single dose intravenous infusions of CNS 5161 to patients with long standing intractable neuropathic pain. A total of 48 patients have received CNS 5161; 10 patients in an initial study and 38 patients in a study completed in 2005. Both studies reported analgesic effects of CNS 5161 at doses that were well tolerated by the patients.


'"/>




Page: 1 2 3

Related medicine technology :

1. Molecular Target of Bradmers Neuradiab Further Validated by Independent Findings
2. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
3. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
4. Study Continues to Show Patients With Myelodysplastic Syndromes Treated With Revlimid are Living Longer and Remaining Transfusion Independent
5. Data Presented at AACR Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Growth of Both Hormone-Dependent and Hormone-Independent Prostate Cancer by Up to 94 Percent in Preclinical Studies
6. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
7. CeNeS Pharmaceuticals Plc Announces Preliminary Results for The Year Ending 31 December 2006
8. CeNeS Pharmaceuticals plc: Update on Successful Phase III results announced on Lead Product M6G
9. Liraglutide provides significantly better glucose control than insulin glargine in phase 3 study
10. Positive results from placebo-controlled phase IIa study in patients suffering from house dust mite allergy
11. Isotechnikas independent data monitoring committee conducts review of phase 2b kidney transplant trial
Post Your Comments:
(Date:5/23/2013)... 2013  Echo Pharma Acquisition Limited ("Royalty Pharma") announced ... Acceptance Threshold from 90 percent to 50 percent of ... accordance with the terms of the Revised Offer Document ... Under the terms of the Increased Offer, Royalty ... ELN ) for $12.50 per share in cash. The ...
(Date:5/23/2013)... 2013 Nederland keurt als eerste ... geassocieerd met BPH Astellas Pharma ... Pharma Inc, gebaseerd in Tokyo ... dat het Nederlandse College ter Beoordeling van Geneesmiddelen (CBG) ... De handelsvergunning verleend voor VESOMNI is voor "de ...
(Date:5/22/2013)... LAGUNA HILLS, Calif. , May 22, 2013 /PRNewswire/ ... is developing a medical device that will help alleviate ... preeclampsia. APT,s targeted apheresis cartridge is expected to be ... a leading cause of maternal and fetal death. ... in the United States . It ...
Breaking Medicine Technology:Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 2Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 3Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 4Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 5Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 6Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 7Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 8Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 9Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share 10Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 2Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 3Astellas ontvangt handelsvergunning voor VESOMNITM van Nederlandse College ter Beoordeling van Geneesmiddelen 4Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2
... YORK, Sept. 16 Reportlinker.com announces that ... in its catalogue: Prosthetic ... Assessment and Market Forecasts to 2016 ... Prosthetic Heart Valves - Global Pipeline Analysis, ...
... MedClean Technologies (OTC Bulletin Board: MCLN ), ... and disposal of medical waste and the destruction of ... signed a distribution agreement with Trojan Energy Systems, Inc., ... years of combined experience in the sale and service ...
Cached Medicine Technology:Reportlinker Adds Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 2Reportlinker Adds Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016 3MedClean Technologies Signs Distribution Agreement with Trojan Energy Systems 2MedClean Technologies Signs Distribution Agreement with Trojan Energy Systems 3
(Date:5/23/2013)... 23, 2013) Aortic arch pulse wave velocity, a ... of disease of the vessels that supply blood to ... the June issue the journal Radiology . ... functional information about vessel compliance that may help determine ... said Kevin S. King, M.D., assistant professor of radiology ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Applied PilotFish ... announced today that it has added support for the ... IDE, the eiConsole for Healthcare. In addition to the ... as LLP, FTP, and Web Services, it now offers ... Direct Protocol is a specification of the Direct ...
(Date:5/23/2013)... Elegance for a woman takes on so many ... her intrigue can often be found in the mystery of her ... soul is through her eyes. It is also true that ... is why the elegance of a woman can be found in ... more than any other time, utilize eyewear to not only compliment ...
(Date:5/23/2013)... Aero Fulfillment Services, a national provider of ... to be the sole fulfillment provider for Olivenol® plus ... Brad Cole, CEO New Wave Biosciences said, “We chose ... location, e-commerce experience with both of our key audiences ... that will expand as our distribution grows.” He ...
(Date:5/23/2013)... Each month Dwell magazine is filled with ... electric cars. Nowhere in America are these pages more scoured ... capital. Thankfully this June, Green Car Journal is bringing its ... Dwell on Design 2013 ( http://www.dwellondesign.com ), America’s ... days of Dwell on Design, June 21-22, attendees and media ...
Breaking Medicine News(10 mins):Health News:MRI-based measurement helps predict vascular disease in the brain 2Health News:PilotFish Expand’s Healthcare Integration Capabilities with Support for the New Direct Protocol in Its Latest Product Release 2Health News:Dolabany Eyewear Adds Feminine Flare to Women's Designer Eyewear with 2013 New Release of Adelina by Best Image Optical, Inc. 2Health News:NewWave Biosciences Chooses Aero Fulfillment for e-Commerce Distribution of New Product to Reduce Inflammation 2Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 2Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 3Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 4Health News:Dwell Media and Green Car Journal Put You in the Driver Seat At Dwell on Design 2013 5
... the lymph nodes also, according to a recent research, led ... immune response. // ,The dreaded disease is ... and the immature parasites travel to the animal's liver. Once ... liver cells and infect red blood cells, beginning the onset ...
... the teenaged girls in the UK are virtually starving themselves to ... Agency and Sugar magazine. // Some of these girls are reported ... 50 per cent always skip breakfast and do not know what ... they eat ‘as little as possible,’ while ten per cent said ...
... risk factors like blood pressure, age and medical history. Those who ... can be treated as outpatients, according to a publication in ... abrupt blockage of an artery due to a blood clot, or ... major health hazard. This is not fatal in the case of ...
... many as 20% of the men in the US suffer ... other diseases, including heart diseases. // The number of visits ... was introduced in 1998. The data available from the National ... S. Saigal and his colleagues. ,About 2,126 men ...
... that as many as 250,000 Scots are unable to access ... Health Department had drawn up an emergency care plan which ... as ?1.5 million has been allocated for this. The situation ... 10% of the population having to wait for a period ...
... a survey in 5 European countries on how women lead ... to find out whether women enjoyed the present life ... the work was funded by Economic and Social Research Council. ... have problems with their family life. ,Researchers found ...
Cached Medicine News:Health News:Malaria Can Develop In Lymph Nodes Also 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: